Upcoming Trade Shows Basel, Switzerland for Biotechnology

The Basel area is fast becoming a dynamic biotechnology hub. To date, the city and its surrounding areas house over 700 companies doing work in biotechnology, digital health, medical technology, chemistry and advanced manufacturing. This region boasts a rich history intertwined with the pharma sector that stems from its textile and chemical industries that birthed the production of synthetic dyes and medicines in the 19th century. These humble beginnings have transformed into international achievements as the city is now home to pharmaceutical giants like Roche, Novartis, Bayer, Johnson & Johnson, Abbott, and hosts the European headquarters of Moderna and BeiGene. All of this is alongside an ecosystem of emerging biotech enterprises such as Idorsia, Roivant Sciences, Skyhawk Therapeutics and T3 Pharma, and venture capitalists and technology parks. A linchpin in the region's sustained growth is the unwavering support provided by Basel Area Business & Innovation. This independent, non-profit agency acts as a guiding force for companies of all sizes and offers assistance with relocation, business consultancy, partnership services, accelerators and networking events. Startups find critical early-stage guidance that also includes assessments of technology readiness and optimal launch timing. One standout initiative by Basel Area Business & Innovation is BaseLaunch: an incubator that’s designed to bridge the funding gap for innovative biotech startups. Serving as a robust growth platform, BaseLaunch facilitates company creation, scientific de-risking and business development. With convertible loans of up to CHF 500,000, it establishes connections with a broad support network encompassing pharma partners, venture capitalists, key opinion leaders and IP law firms. Startups benefit from access to essential labs and infrastructure. This comprehensive package and the wealth of expertise ensure a trajectory from inception to Series A funding for budding biotech enterprises, solidifying Basel's status as a beacon of biotechnological innovation.